These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1918710)

  • 1. High dose titration of calcium channel blocking agents for primary pulmonary hypertension: guidelines for short-term drug testing.
    Rich S; Kaufmann E
    J Am Coll Cardiol; 1991 Nov; 18(5):1323-7. PubMed ID: 1918710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of adenosine in combination with calcium channel blockers in patients with primary pulmonary hypertension.
    Inbar S; Schrader BJ; Kaufmann E; Vestal RE; Rich S
    J Am Coll Cardiol; 1993 Feb; 21(2):413-8. PubMed ID: 8426006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.
    Rich S; Brundage BH
    Circulation; 1987 Jul; 76(1):135-41. PubMed ID: 2954725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.
    Sitbon O; Humbert M; Jagot JL; Taravella O; Fartoukh M; Parent F; Herve P; Simonneau G
    Eur Respir J; 1998 Aug; 12(2):265-70. PubMed ID: 9727772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension.
    Rich S; Kaufmann E; Levy PS
    N Engl J Med; 1992 Jul; 327(2):76-81. PubMed ID: 1603139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of nifedipine, verapamil, and diltiazem on experimental pulmonary hypertension.
    Young TE; Lundquist LJ; Chesler E; Weir EK
    Am J Cardiol; 1983 Jan; 51(1):195-200. PubMed ID: 6571766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease.
    Packer M; Medina N; Yushak M
    J Am Coll Cardiol; 1984 Nov; 4(5):890-901. PubMed ID: 6491082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease.
    Alpert MA; Pressly TA; Mukerji V; Lambert CR; Mukerji B; Panayiotou H; Sharp GC
    Am J Cardiol; 1991 Dec; 68(17):1687-91. PubMed ID: 1746473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators.
    Houde C; Bohn DJ; Freedom RM; Rabinovitch M
    Br Heart J; 1993 Nov; 70(5):461-8. PubMed ID: 8260279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of adenosine and nifedipine in pulmonary hypertension.
    Schrader BJ; Inbar S; Kaufmann L; Vestal RE; Rich S
    J Am Coll Cardiol; 1992 Apr; 19(5):1060-4. PubMed ID: 1552096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled nitric oxide in primary pulmonary hypertension: a safe and effective agent for predicting response to nifedipine.
    Ricciardi MJ; Knight BP; Martinez FJ; Rubenfire M
    J Am Coll Cardiol; 1998 Oct; 32(4):1068-73. PubMed ID: 9768734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of nifedipine, verapamil and diltiazem on pulmonary vascular resistance and vasoconstrictors in cats.
    Erdemli O; Hao Q; Cai B; Lippton HL; Hyman A
    Arch Int Pharmacodyn Ther; 1994; 328(2):165-79. PubMed ID: 7535994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential therapy with calcium antagonists in pulmonary hypertension secondary to COPD. Hemodynamic effects of nifedipine, diltiazem, and verapamil.
    Gassner A; Sommer G; Fridrich L; Magometschnigg D; Priol A
    Chest; 1990 Oct; 98(4):829-34. PubMed ID: 2209138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of diltiazem during vasoconstrictor pulmonary hypertension in sheep.
    Pearl RG; Finn JC
    Anesth Analg; 1990 Nov; 71(5):493-7. PubMed ID: 2221409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the acute pulmonary vascular effects of oxygen with nitric oxide and diltiazem: implications for the long-term treatment of pulmonary arterial hypertension.
    Day RW
    Congenit Heart Dis; 2013; 8(1):71-7. PubMed ID: 22891699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of nifedipine on secondary pulmonary hypertension in man.
    Garzaniti N; el Allaf D; D'Orio V; Cremers S; Marcelle R; Carlier J
    Acta Cardiol; 1985; 40(2):207-15. PubMed ID: 3873156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the effects of vasodilator therapy in primary pulmonary hypertension. Experience in 7 cases].
    Lanzarini L; Gavazzi A; Mussini A; Graziano G; Campana C; Bargiggia G; Angoli L; Aimè E; Arbustini E; Montemartini C
    G Ital Cardiol; 1990 Feb; 20(2):114-22. PubMed ID: 2328864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute nonhemodynamic pulmonary edema with nifedipine in primary pulmonary hypertension.
    Prigogine T; Waterlot Y; Gottignies P; Verhoeven A; Decroly P
    Chest; 1991 Aug; 100(2):563-4. PubMed ID: 1864141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertension.
    Barst RJ
    Chest; 1986 Apr; 89(4):497-503. PubMed ID: 2869919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic effects of nifedipine in primary pulmonary hypertension.
    Douglas JS
    J Am Coll Cardiol; 1983 Jul; 2(1):174-9. PubMed ID: 6853910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.